All lobbying filings

CGCN Group, LLC

CGCN Group, LLC filed a Q4 report for Alvogen, Inc. on January 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Alvogen, Inc. · Pharmaceuticals company

As filed: CGCN GROUP, LLC for ALVOGEN, INC.

All filings by CGCN Group, LLC · Everything Alvogen, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Issues related to domestic manufacturing and on-shoring pharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem